Oracle (NYSE: ORCL) shares are now trading at roughly 10 times the adjusted earnings per share analysts expect the company to deliver in fiscal year 2028, which closes in May of that year.
That valuation emerges from a capital raise that surprised markets both in scale and in the depth of the discount Oracle accepted to get the deal done.
The cloud computing giant priced 86.2 million new shares at $116 each, generating net proceeds of approximately $9.9 billion as part of a broader $20 billion financing that also included a multi-tranche notes offering.
The $116 price tag represented a discount of roughly 11% to Oracle’s closing price of $130.67 on the final trading day of October, a steeper haircut than many analysts had anticipated going into the transaction.
Early expectations had centered on roughly 69 million new shares priced near $145 apiece, meaning the actual deal delivered approximately a quarter more shares into the market than the street had modeled.
That pricing gap matters because it directly determines the degree of dilution shareholders absorb, with Oracle’s total share count set to rise by around 3%, climbing from 3.02 billion shares outstanding at the end of August to approximately 3.11 billion.
The move follows an already aggressive period of equity issuance: Oracle had previously sold $20 billion in stock through an at-the-market program during its fiscal first quarter of 2027, which ended August 31.
On the debt side of the $20 billion package, the five-note issuance carries a combined annual interest burden of approximately $780 million, a recurring cost that investors will need to weigh against the company’s earnings trajectory.
Despite those obligations, the pricing of the new shares may itself serve as a reference point for value-conscious investors, given that $116 now represents a level at which institutional buyers were willing to commit capital in size.
For retail investors evaluating entry points, the $116 level offers a concrete benchmark: it is where Oracle’s newest shareholders bought in, and at roughly 10 times fiscal 2028 expected adjusted earnings, the valuation case for adding shares gradually around that price is not difficult to construct.
